Slade has been providing exceptional services to the Australian hospital, pharmacy and aged care sectors for nearly 60 years. In 2022, Slade entered into a long-term agreement with Te Toka Tuma Auckland to service Auckland District Hospital and associated hospitals and to meet the growing needs of cancer patients in the region. This agreement has seen Slade design, build and operate a world-class, Medsafe licensed sterile compounding facility delivering chemotherapy, antibiotics, and analgesics for public and private hospitals across New Zealand.
Learn more about Slade’s commitment to quality by viewing the video below.